CAR-T Cell and Gene Therapy Market: Challenges and Opportunities

Of the estimated 6,800 rare diseases (defined here as affecting fewer than 200,000 people) that are caused by genetic mutations, more than 95% have no approved therapeutic option.

    • Tags:

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Q: